Cost-effectiveness analyses of drug eluting stents versus bare metal stents: A systematic review of the literature
- 31 July 2009
- journal article
- review article
- Published by Elsevier BV in Health Policy
- Vol. 91 (2), 107-120
- https://doi.org/10.1016/j.healthpol.2008.11.014
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Drug-eluting stents: do the risks really outweigh the benefits?Heart, 2008
- Drug-Eluting StentsCirculation, 2006
- Cost Effectiveness of Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization: Results From the TAXUS-IV TrialJournal of the American College of Cardiology, 2006
- Drug eluting stents: an updated meta-analysis of randomised controlled trialsHeart, 2006
- Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: results from the RESEARCH RegistryEuropean Heart Journal, 2006
- What reimbursement for coronary revascularization with drug-eluting stents?The European Journal of Health Economics, 2004
- Economic impact of drug-eluting stents on hospital systems: a disease-state modelAmerican Heart Journal, 2004
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseThe New England Journal of Medicine, 2001
- One-Year Follow-Up of The Stent Restenosis (STRESS I) StudyThe American Journal of Cardiology, 1998
- Parameter Estimates for a QALY Utility ModelMedical Decision Making, 1985